BPC-157 Often associated with tissue repair and inflammation control Sermorelin A growth hormonereleasing peptide GLP-1 agonists Originally developed for blood sugar regulation and weight loss But heres the twist: none of these were originally designed specifically for skin
, 3 , CD004326
Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, et al
During an evaluation, providers may review: Recommendations are based on individual medical evaluation and clinical judgment
Benefits & Considerations Potential Benefits: Greater total fat loss Reduced hunger and cravings Possible metabolic improvements beyond semaglutide May help maintain results long-term Considerations: Not yet FDA-approved Side effects may overlap (nausea, constipation, fatigue) Long-term safety data still limited Why This Matters for the Future of Weight Management The combination of Retatrutide + Cagrilintide represents the next evolution of metabolic pharmacology, one that treats obesity like the complex, multi-hormonal disease it is
Scientists for the agency spoke extensively about the lack of reliable data for any of the seven peptides before the committee
